Epicardial fat thickness is associated with non-dipper blood pressure pattern in patients with essential hypertension

Clinical and Experimental Hypertension

Volumn 34, Issue 3, 2012, Pages 165-170

  Sengul, Cihan ^a   Cevik, Cihan ^b   Ozveren, Olcay ^c   Duman, Dursun ^d   Eroglu, Elif ^c   Oduncu, Vecih ^c   Tanboga, Halil Ibrahim ^c   Can, Mehmet Mustafa ^c   Akgun, Taylan ^c   Dindar, Ismet ^a  

^a MEDICAL PARK HOSPITAL   (Turkey)

^b ST LUKE S EPISCOPAL HOSPITAL   (United States)

^c KOSUYOLU HEART AND RESEARCH HOSPITAL   (Turkey)

^d GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

Author keywords

Echocardiography; Epicardial fat; Hypertension; Non dipper; Visceral adiposity

Indexed keywords

ABDOMINAL OBESITY; ADULT; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; EPICARDIAL FAT THICKNESS; ESSENTIAL HYPERTENSION; EXERCISE TEST; FEMALE; HEART LEFT VENTRICLE MASS; HUMAN; MALE; NON DIPPER BLOOD PRESSURE; RECEIVER OPERATING CHARACTERISTIC; SYSTOLIC BLOOD PRESSURE; TRANSTHORACIC ECHOCARDIOGRAPHY; TREADMILL EXERCISE;

ADULT; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CIRCADIAN RHYTHM; ECHOCARDIOGRAPHY; FEMALE; HUMANS; HYPERTENSION; INTRA-ABDOMINAL FAT; MALE; MIDDLE AGED; PERICARDIUM; RISK FACTORS;

EID: 84859747711     PISSN: 10641963     EISSN: 15256006     Source Type: Journal    
DOI: 10.3109/10641963.2011.577488     Document Type: Article

References (40)

1. O'Brien E, Sheridan J, O'Malley K. Dippers and non-dippers. Lancet 1988; 13:397.
2. Palatini P. Non-dipping in hypertension: Still a challenging problem. J Hypertens 2004; 22:2303-2309.
3. Imai Y, Abe K, Sasaki S, et al. Circadian blood pressure variation in patients with renovascular hypertension or primary aldosteronism. Clin Exp Hypertens A 1992; 14:1142-1167.
4. Rahman M, Griffin V, Heyka R, Hoit B. Diurnal variation of blood pressure; reproducibility and association with left ventricular hypertrophy in hemodialysis patients. Blood Press Monit 2005; 10:25-32. (Pubitemid 40316149)
5. De La SA, Lluch MM, Coca A, et al. Assessment of salt sensitivity in essential hypertension by 24-h ambulatory blood pressure monitoring. Am. J. Hypertens 1995; 8:970-977.
6. Sironi AM, Gastaldelli A, Mari A, et al. Fat in hypertension: Influence on insulin resistance and beta-cell function. Hypertension 2004; 44:127-133. (Pubitemid 39014227)
7. Sironi AM, Pingitore A, Ghione S, et al. Early hypertension is associated with reduced regional cardiac function, insulin resistance, epicardial, and visceral fat. Hypertension 2008; 51:282-288. (Pubitemid 351159940)
8. Iacobellis G, Corradi D, Sharma AM. Epicardial adipose tissue: Anatomic, biomolecular and clinical relationship with the heart. Nat Clin Pract Cardivasc Med 2005; 2:536-543. (Pubitemid 41670345)
9. Kotsis V, Stabouli S, Bouldin M, et al. Impact of obesity on 24-hour ambulatory blood pressure and hypertension. Hypertension 2005; 45:602-607. (Pubitemid 40411267)
10. Cuspidi C, Meani S, Valerio C, et al. Body mass index, nocturnal fall in blood pressure and organ damage in untreated essential hypertensive patients. Blood Press Monit 2008; 13: 318-324.
11. National Cholesterol Education Program (NCEP). Expert panel on detection, evaluation, and treatment of high blood cholesterol in Adults (Adult Treatment Panel III) Third Report of the National Cholesterol Education Program (NCEP) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 2002; 106:3143-3421.
12. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28:412-419. (Pubitemid 15018832)
13. Henry WL, DeMaria A, Gramiak R, et al. Report of the American Society of Echocardiography Committee on nomenclature and standards in 2-dimensional echocardiography. Circulation 1980; 62:212-217. (Pubitemid 10035638)
14. Devereux RB. Detection of left ventricular hypertrophy by M-mode echocardiography: Anatomic validation, standardization, and comparison to other methods. Hypertension 1987; 9: 19-26.
15. Iacobellis G, Ribaudo MC, Assael F, et al. Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: A new indicator of cardiovascular risk. J Clin Endocrinol. Metab. 2003; 88: 5163-5168. (Pubitemid 37452712)
16. O'Brien E, Asmar R, Beilin L, et al. European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens 2003; 21:821-848. (Pubitemid 36677141)
17. Chuang SY, Chou P, Hsu PF, et al. Presence and progression of abdominal obesity are predictors of future high blood pressure and hypertension. Am. J. Hypertens 2006; 19:788-795. (Pubitemid 44107694)
18. Rhéaume C, Arsenault BJ, Bélanger S, et al. Low cardiorespiratory fitness levels and elevated blood pressure: What is the contribution of visceral adiposity? Hypertension 2009; 54: 91-97.
19. Garrison RJ, Kannel WB, Stokes J 3rd, Castelli WP. Incidence and precursors of hypertension in young adults: The Framingham Offspring Study. Prev Med 1987; 16:235-251. (Pubitemid 17067798)
20. Iacobellis G, Barbaro G. The double role of epicardial adipose tissue as pro- and anti-inflammatory organ. Horm Metab Res 2008; 40:442-445.
21. Marchington JM, Mattacks CA, Pond CM. Adipose tissue in the mammalian heart and pericardium: Structure, fetal development and biochemical properties. Comp Biochem Physiol B 1989; 94:225-232.
22. Manzella D, Barbieri M, Rizzo MR, et al. Free fatty acids on cardiac autonomic nervous system in noninsulindependent diabetic patients: Effects of metabolic control. J Clin Endocrinol. Metab. 2001; 86:2769-2774. (Pubitemid 32545737)
23. Bambace C, Telesca M, Zoico E, et al. Adiponectin gene expression and adipocyte diameter: A comparison between epicardial and subcutaneous adipose tissue in men. Cardiovasc Pathol 2010 Sep 7 2011; 20:e153-6.
24. Teijeira-Fernandez E, Eiras S, Grigorian-Shamagian L, et al. Epicardial adipose tissue expression of adiponectin is lower in patients with hypertension. J Hum Hypertens 2008; 22:856-863.
25. Hojo Y, Noma S, Ohki T, Nakajima H, Satoh Y. Autonomic nervous system activity in essential hypertension: A comparison between dippers and non-dippers. J Hum Hypertens 1997; 11:665-671. (Pubitemid 27494062)
26. Birkenhäger AM, Van Den Meiracker AH. Causes and consequences of a non-dipping blood pressure profile. Neth J Med 2007; 65:127-131. (Pubitemid 46656849)
27. Della Mea P, Lupia M, Bandolin V, et al. Adiponectin, insulin resistance, and left ventricular structure in dipper and nondipper essential hypertensive patients. Am. J. Hypertens 2005; 18:30-35. (Pubitemid 40187346)
28. Iacobellis G, Barbaro G, Gerstein HC. Relationship of epicardial fat thickness and fasting glucose. Int. J. Cardiol 2008; 128:424-426.
29. Aydin H, Toprak A, Deyneli O, et al. Epicardial fat tissue thickness correlates with endothelial dysfunction and other cardiovascular risk factors in patients with metabolic syndrome. Metab Syndr Relat Disord 2010; 8:229-234.
30. Ragot S, Herpin D, Siche JP, Ingrand P, Mallion JM. Autonomic nervous system activity in dipper and non-dipper essential hypertensive patients. What about sex differences? J Hypertens 1999; 17:1805-1811. (Pubitemid 30345314)
31. Lurbe E, Redon J, Pascual JM, Tacons J, Alvares V. The spectrum of circadian blood pressure changes in type I diabetic patients. J Hypertens 2001; 19:1421-1428. (Pubitemid 32730459)
32. Nakano S, Kitazawa M, Tsuda S, et al. Insulin resistance is associated with reduced nocturnal falls of blood pressure in normotensive, nonobese type 2 diabetic subjects. Clin Exp Hypertens 2002; 24:65-73. (Pubitemid 34132363)
33. Chen JW, Jen SL, Lee WL, et al. Differential glucose tolerance in dipper and nondipper essential hypertension: The implications of circadian blood pressure regulation on glucose tolerance in hypertension. Diabetes Care 1998; 21:1743-1746.
34. Anan F, Takahashi N, Ooie T, et al. Role of insulin resistance in nondipper essential hypertensive patients. Hypertens Res 2003; 26:669-676. (Pubitemid 37258652)
35. Tartan Z, Uyarel H, Kasikcioglu H, et al. Metabolic syndrome as a predictor of non-dipping hypertension. Tohoku J Exp Med 2006; 210:57-66. (Pubitemid 44377790)
36. Diamantopoulos EJ, Andreadis E, Tsourous G, et al. Insulin resistance and blood pressure circadian variation in an obese hypertensive population. Clin Exp Hypertens 2006; 28: 625-630. (Pubitemid 44581977)
37. Hoshide S, Kario K, Hoshide Y, et al. Associations between nondipping of nocturnal blood pressure decrease and cardiovascular target organ damage in strictly selected communitydwelling normotensives. Am. J. Hypertens 2003; 16:434-438. (Pubitemid 36667796)
38. Soylu A, Duzenli MA, YaziciM, et al. The effect of nondipping blood pressure patterns on cardiac structural changes and left ventricular diastolic functions in normotensives. Echocardiography 2009; 26:378-387.
39. Cuspidi C, Meani S, Salerno M, et al. Cardiovascular target organ damage in essential hypertensives with or without reproducible nocturnal fall in blood pressure. J Hypertens 2004; 22:273-280. (Pubitemid 38250985)
40. Ijiri H, Kohno I, Yin D, et al. Cardiac arrhythmias and left ventricular hypertrophy in dipper and nondipper patients with essential hypertension. Jpn Circ J 2000; 64:499-504. (Pubitemid 30456693)